A031704: D-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab Vs. VEGF TKI Cabozantinib with Nivolumab: A Phase III Trial in Metastatic Untreated REnal Cell CancEr [PDIGREE] (Location: Aberdeen) (temporarily closed to enrollment effective 15-May-2024)

Objective

Clinical Trial Details >>

Principal Investigator(s)
Benjamin Solomon, MD

Clinical Trial Categories

  • Renal/Urinary Tract Cancer
Contact
Medical Oncology Research Coordinators at 605-322-3295
or medoncresearch@avera.org

Location

  • Avera Cancer Institute — Aberdeen
    310 S Penn St
    Suite 106
    Aberdeen, SD 57401
    Main: 605-622-8700